Cargando…
A Dynamic Quantitative Systems Pharmacology Model of Inflammatory Bowel Disease: Part 1 – Model Framework
A mechanistic, multistate, mathematical model of inflammatory bowel disease (IBD) was developed by including key biological mechanisms in blood and gut, including cell differentiation, cytokine production, and clinical biomarkers. The model structure is consistent between healthy volunteers and IBD...
Autores principales: | Rogers, Katharine V., Martin, Steven W., Bhattacharya, Indranil, Singh, Ravi Shankar Prasad, Nayak, Satyaprakash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877855/ https://www.ncbi.nlm.nih.gov/pubmed/32822108 http://dx.doi.org/10.1111/cts.12849 |
Ejemplares similares
-
A Dynamic Quantitative Systems Pharmacology Model of Inflammatory Bowel Disease: Part 2 – Application to Current Therapies in Crohn’s Disease
por: Rogers, Katharine V., et al.
Publicado: (2020) -
Know Your Variability: Challenges in Mechanistic Modeling of Inflammatory Response in Inflammatory Bowel Disease (IBD)
por: Rogers, Katharine V., et al.
Publicado: (2017) -
A systems pharmacology model for inflammatory bowel disease
por: Balbas-Martinez, Violeta, et al.
Publicado: (2018) -
Computational Modeling and Analysis of Insulin Induced Eukaryotic Translation Initiation
por: Lequieu, Joshua, et al.
Publicado: (2011) -
Getting Innovative Therapies Faster to Patients at the Right Dose: Impact of Quantitative Pharmacology Towards First Registration and Expanding Therapeutic Use
por: Nayak, Satyaprakash, et al.
Publicado: (2018)